vs

Side-by-side financial comparison of Inotiv, Inc. (NOTV) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.

UNIVERSAL TECHNICAL INSTITUTE INC is the larger business by last-quarter revenue ($221.4M vs $120.9M, roughly 1.8× Inotiv, Inc.). UNIVERSAL TECHNICAL INSTITUTE INC runs the higher net margin — 0.2% vs -23.5%, a 23.7% gap on every dollar of revenue. On growth, UNIVERSAL TECHNICAL INSTITUTE INC posted the faster year-over-year revenue change (6.7% vs 0.8%). Over the past eight quarters, UNIVERSAL TECHNICAL INSTITUTE INC's revenue compounded faster (11.7% CAGR vs 0.8%).

Inotiv, Inc. is a contract research organization organized in Indiana and headquartered in Lafayette, Indiana. The company operates two core business units: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The CRS business unit offers drug development and environmental sciences services, including safety assessment, analytical, metabolism, CMC and regulatory consultancy for small molecule drug candidates, biotherapeutics, and biomedical devices. The RMS business u...

Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.

NOTV vs UTI — Head-to-Head

Bigger by revenue
UTI
UTI
1.8× larger
UTI
$221.4M
$120.9M
NOTV
Growing faster (revenue YoY)
UTI
UTI
+5.9% gap
UTI
6.7%
0.8%
NOTV
Higher net margin
UTI
UTI
23.7% more per $
UTI
0.2%
-23.5%
NOTV
Faster 2-yr revenue CAGR
UTI
UTI
Annualised
UTI
11.7%
0.8%
NOTV

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
NOTV
NOTV
UTI
UTI
Revenue
$120.9M
$221.4M
Net Profit
$-28.4M
$433.0K
Gross Margin
Operating Margin
-13.5%
0.2%
Net Margin
-23.5%
0.2%
Revenue YoY
0.8%
6.7%
Net Profit YoY
-2.7%
-60.5%
EPS (diluted)
$-0.83
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NOTV
NOTV
UTI
UTI
Q1 26
$221.4M
Q4 25
$120.9M
$220.8M
Q3 25
$138.1M
$222.4M
Q2 25
$130.7M
$204.3M
Q1 25
$124.3M
$207.4M
Q4 24
$119.9M
$201.4M
Q3 24
$130.4M
$196.4M
Q2 24
$105.8M
$177.5M
Net Profit
NOTV
NOTV
UTI
UTI
Q1 26
$433.0K
Q4 25
$-28.4M
$12.8M
Q3 25
$-8.6M
$18.8M
Q2 25
$-17.6M
$10.7M
Q1 25
$-14.9M
$11.4M
Q4 24
$-27.6M
$22.2M
Q3 24
$-18.9M
$18.8M
Q2 24
$-26.1M
$5.0M
Operating Margin
NOTV
NOTV
UTI
UTI
Q1 26
0.2%
Q4 25
-13.5%
7.1%
Q3 25
-4.9%
11.2%
Q2 25
-4.3%
6.9%
Q1 25
-2.4%
8.1%
Q4 24
-12.9%
13.6%
Q3 24
-10.1%
13.3%
Q2 24
-19.6%
4.2%
Net Margin
NOTV
NOTV
UTI
UTI
Q1 26
0.2%
Q4 25
-23.5%
5.8%
Q3 25
-6.2%
8.4%
Q2 25
-13.5%
5.2%
Q1 25
-12.0%
5.5%
Q4 24
-23.0%
11.0%
Q3 24
-14.5%
9.6%
Q2 24
-24.7%
2.8%
EPS (diluted)
NOTV
NOTV
UTI
UTI
Q1 26
$0.01
Q4 25
$-0.83
$0.23
Q3 25
$-0.14
$0.33
Q2 25
$-0.51
$0.19
Q1 25
$-0.44
$0.21
Q4 24
$-1.02
$0.40
Q3 24
$-0.73
$0.35
Q2 24
$-1.00
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NOTV
NOTV
UTI
UTI
Cash + ST InvestmentsLiquidity on hand
$12.7M
$162.0M
Total DebtLower is stronger
$405.8M
$127.8M
Stockholders' EquityBook value
$109.0M
$339.9M
Total Assets
$734.3M
$852.2M
Debt / EquityLower = less leverage
3.72×
0.38×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NOTV
NOTV
UTI
UTI
Q1 26
$162.0M
Q4 25
$12.7M
$162.8M
Q3 25
$21.7M
$169.1M
Q2 25
$6.2M
$70.7M
Q1 25
$19.3M
$96.0M
Q4 24
$38.0M
$172.0M
Q3 24
$21.4M
$161.9M
Q2 24
$14.4M
$115.5M
Total Debt
NOTV
NOTV
UTI
UTI
Q1 26
$127.8M
Q4 25
$405.8M
$101.4M
Q3 25
$402.1M
$87.1M
Q2 25
$396.5M
$73.8M
Q1 25
$399.5M
$94.4M
Q4 24
$396.0M
$120.1M
Q3 24
$393.3M
$125.7M
Q2 24
$382.4M
$137.3M
Stockholders' Equity
NOTV
NOTV
UTI
UTI
Q1 26
$339.9M
Q4 25
$109.0M
$335.9M
Q3 25
$136.0M
$328.1M
Q2 25
$143.8M
$306.8M
Q1 25
$157.7M
$293.9M
Q4 24
$169.8M
$280.0M
Q3 24
$170.5M
$260.2M
Q2 24
$182.1M
$239.4M
Total Assets
NOTV
NOTV
UTI
UTI
Q1 26
$852.2M
Q4 25
$734.3M
$834.0M
Q3 25
$771.1M
$826.1M
Q2 25
$759.7M
$740.8M
Q1 25
$766.0M
$720.4M
Q4 24
$772.9M
$753.8M
Q3 24
$781.4M
$744.6M
Q2 24
$774.6M
$706.0M
Debt / Equity
NOTV
NOTV
UTI
UTI
Q1 26
0.38×
Q4 25
3.72×
0.30×
Q3 25
2.96×
0.27×
Q2 25
2.76×
0.24×
Q1 25
2.53×
0.32×
Q4 24
2.33×
0.43×
Q3 24
2.31×
0.48×
Q2 24
2.10×
0.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NOTV
NOTV
UTI
UTI
Operating Cash FlowLast quarter
$-5.4M
$7.1M
Free Cash FlowOCF − Capex
$-10.6M
FCF MarginFCF / Revenue
-8.8%
Capex IntensityCapex / Revenue
4.3%
Cash ConversionOCF / Net Profit
16.33×
TTM Free Cash FlowTrailing 4 quarters
$-28.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NOTV
NOTV
UTI
UTI
Q1 26
$7.1M
Q4 25
$-5.4M
$3.1M
Q3 25
$14.3M
$57.1M
Q2 25
$-7.4M
$18.1M
Q1 25
$-12.8M
$-789.0K
Q4 24
$-4.5M
$23.0M
Q3 24
$-2.4M
$67.5M
Q2 24
$-14.8M
$10.0M
Free Cash Flow
NOTV
NOTV
UTI
UTI
Q1 26
Q4 25
$-10.6M
$-19.2M
Q3 25
$11.6M
$40.6M
Q2 25
$-11.5M
$6.8M
Q1 25
$-18.3M
$-11.7M
Q4 24
$-9.0M
$19.6M
Q3 24
$-7.7M
$60.0M
Q2 24
$-19.2M
$3.0M
FCF Margin
NOTV
NOTV
UTI
UTI
Q1 26
Q4 25
-8.8%
-8.7%
Q3 25
8.4%
18.3%
Q2 25
-8.8%
3.4%
Q1 25
-14.7%
-5.7%
Q4 24
-7.5%
9.7%
Q3 24
-5.9%
30.6%
Q2 24
-18.2%
1.7%
Capex Intensity
NOTV
NOTV
UTI
UTI
Q1 26
Q4 25
4.3%
10.1%
Q3 25
1.9%
7.4%
Q2 25
3.1%
5.5%
Q1 25
4.4%
5.3%
Q4 24
3.7%
1.7%
Q3 24
4.1%
3.8%
Q2 24
4.2%
4.0%
Cash Conversion
NOTV
NOTV
UTI
UTI
Q1 26
16.33×
Q4 25
0.24×
Q3 25
3.04×
Q2 25
1.69×
Q1 25
-0.07×
Q4 24
1.04×
Q3 24
3.58×
Q2 24
2.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NOTV
NOTV

Research Models And Services Segment$72.9M60%
Discovery And Safety Assessment Segment$48.0M40%

UTI
UTI

Segment breakdown not available.

Related Comparisons